Imgae (4172f029 3c4e 4cc8 Ade0 F96b9d9b7c71 01)
Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 68180-840
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 68180-840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (4172f029 3c4e 4cc8 Ade0 F96b9d9b7c71 02)
This text provides information on various studies conducted to evaluate the risk of breast cancer associated with the use of combined oral contraceptives. It includes the names of the studies along with their respective years, such as NIGHD Women's Contraceptive Study (2002), Shanghai Women's Health Study (2009), The Nurses' Health Study 1 (2010), and others. Additionally, it includes the effect estimate which could be risk ratio (RR) or odds ratio (OR).*
Image (4172f029 3c4e 4cc8 Ade0 F96b9d9b7c71 03)
Ethinyl Estradiol is a synthetic form of the naturally occurring estrogen hormone estradiol. It is commonly used in combination with a progestin hormone to prevent pregnancy in women by inhibiting ovulation. Additionally, it may be used to treat conditions such as acne, polycystic ovary syndrome, and hirsutism. Ethinyl Estradiol is available in various dosage forms including tablets and patches. It should only be used under the guidance of a healthcare provider.*
Image (4172f029 3c4e 4cc8 Ade0 F96b9d9b7c71 04)
This text is describing different methods of birth control and their effectiveness. It breaks down the number of pregnancies per 100 women in one year for different methods ranging from less than 1 for highly effective methods like implants, injections, intrauterine devices, and sterilization, to 10-20 for moderately effective methods like birth control pills, skin patch, or vaginal ring with hormones, to 85 or more for less effective methods like condoms, diaphragm, no sex during the most fertile days of the monthly cycle, spermicide, withdrawal or no birth control.*
Image (4172f029 3c4e 4cc8 Ade0 F96b9d9b7c71 05)
Image (4172f029 3c4e 4cc8 Ade0 F96b9d9b7c71 06)
Image (4172f029 3c4e 4cc8 Ade0 F96b9d9b7c71 07)
Dot Knuring and Fin seal are terms commonly used in the packaging industry. Unfortunately, there is not enough context to provide a comprehensive description. "This side to be sealed at vendor end" likely refers to a specific instruction for sealing the package.*
Image (4172f029 3c4e 4cc8 Ade0 F96b9d9b7c71 08)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
